PR Newswire
23 Oct 2023, 15:23 GMT+10
SHENZHEN, China, Oct. 23, 2023 /PRNewswire/ -- Mindray (SZSE: 300760), a global leader in medical devices and solutions, introduces high-sensitivity troponin I (hs-cTnI) and NT-proBNP cardiac biomarkers. The additions have enhanced Mindray's diverse portfolio of cardiac biomarkers for cardiovascular diseases (CVDs) diagnosis and management.
While CVDs are the leading cause of death worldwide, early detection is key in saving lives. Guidelines recommend the use of cTnl and NT-proBNP as essential biomarkers for suspected Acute Coronary Syndrome (ACS) and heart failure in early screening, risk stratification, rapid diagnosis, and therapeutic monitoring.
The two assays are the collaborative effort of Mindray and HyTest, a Mindray company and a prominent global provider of antibodies and antigens. HyTest, renowned for its cardiac biomarker expertise, had its cardiac troponin complex material selected as the international troponin standard by AACC in 2004.
Validated by Wuhan Asian Heart Hospital in China and Hennepin Healthcare Research Institute in the U.S., both assays showcase outstanding clinical performance.
Mindray hs-cTnI Assay: reliable myocardial injury detection with a high detection rate and a low CV
Mindray's hs-cTnI assay far surpasses the minimum requirements for hs-cTn by achieving a remarkable 93% detection rate between LoD and 99th URL and an imprecision CV below 5% at the 99th URL. This demonstrates the assay's exceptional sensitivity, precision, and reliability in detecting myocardial injury. Furthermore, a 0-2h diagnostic algorithm study conducted at the Hennepin Healthcare Research Institute further supports its effectiveness in diagnosing and managing cardiac conditions within this crucial timeframe.
Mindray NT-proBNP Assay with high precision and strong anti-interference capacity
NT-proBNP is an established cardiac marker for heart failure and its management. Mindray's NT-proBNP assay demonstrates high precision with a CV of 5% and effectively minimizes interference from 55 common medications for heart diseases, proving its reliability for heart failure detection and management.
"Through integrating HyTest's pioneering antibodies and research on cardiac biomarkers with Mindray's advanced reagent technology and platform, we will deliver more reliable solutions that bring improved patient outcomes in the field of cardiovascular diseases and beyond," said Dr. Jianwen He, Chief Scientific Officer of Mindray IVD.
About Mindray
Mindray is a leading developer, manufacturer, and supplier of medical devices and solutions that empower healthcare professionals worldwide with innovative, life-saving tools in Patient Monitoring and Life Support, In-Vitro Diagnostics, Medical Imaging and Orthopaedics.
Website: https://www.mindray.com/en
Get a daily dose of Singapore Star news through our daily email, its complimentary and keeps you fully up to date with world and business news as well.
Publish news of your business, community or sports group, personnel appointments, major event and more by submitting a news release to Singapore Star.
More InformationWASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
LONDON, U.K.: British Prime Minister Keir Starmer and New Zealand Prime Minister Christopher Luxon decided to strengthen their countries'...
WASHINGTON, D.C.: The U.S. Food and Drug Administration (FDA) is stopping a quality control program that tests milk and other dairy...
WASHINGTON, D.C. A Delta Air Lines plane with nearly 300 people on board had an engine fire after leaving the gate at Orlando International...
WASHINGTON, D.C.: In November, a passenger plane was about to land at San Francisco airport when the pilots suddenly saw a drone flying...
LAHORE, Pakistan: A Christian man in the town of Jaranwala, in eastern Pakistan, will appeal a death sentence given to him by an anti-terrorism...
WASHINGTON, D.C.: The United States plans to press India for sweeping changes to its e-commerce policies as part of negotiations aimed...
BEIJING, China: China's automobile exports rose sharply in the first quarter of 2024, with 1.54 million vehicles shipped abroad, marking...
BEIJING, China: At Home Plate BBQ in Beijing, the iconic Texan brisket is about to get a new passport. The restaurant, known for its...
NEW YORK, New York - Stocks were largely higher on Friday with all the indices notching up daily and weekly gains. Steadying the markets...
NEW YORK CITY, New York: Stores that sell secondhand clothes, shoes, and accessories might actually benefit from President Trump's...
CHICAGO, Illinois: Motorola Solutions rolled out a new multi-functional device aimed at streamlining emergency response for law enforcement...